Veridia · Pharmaceutical quality intelligence

PHARMACEUTICAL QUALITY INTELLIGENCE

Evidence connected.
People in control.

A proposed workflow for finding the right documents, assembling evidence-linked drafts and keeping quality decisions with qualified professionals.

SaaS initiative in development · Proposed capabilities

Proposed workflow

From fragmented records
to connected evidence.

A focused sequence for the deviation-to-CAPA cycle, with human review at the decision point.

  1. 01

    Prepare the document collection

    Ingest authorized customer SOPs, batch records, deviations, CAPAs, training records and supplier documentation. Keep each customer’s corpus isolated by default.

    CUSTOMER EVIDENCE
  2. 02

    Capture the deviation

    Record the event and its context so retrieval can focus on relevant procedures, prior investigations and affected materials.

    DEVIATION INTAKE
  3. 03

    Retrieve and connect

    Find similar investigations and applicable source passages. If supplier materials are involved, bring relevant supplier regulatory history into the same workflow.

    CITED CONTEXT
  4. 04

    Draft an investigation and CAPA

    Use retrieved material to propose an investigation narrative, candidate root causes and corrective and preventive action documentation. Draft paragraphs are intended to cite their supporting sources.

    AI-ASSISTED DRAFT
  5. 05

    Review, edit and approve

    Qualified quality professionals inspect the sources, test the reasoning, revise the draft and determine the final investigation and CAPA.

    HUMAN DECISION
  6. 06

    Retain provenance

    Record the sources behind AI-surfaced content and the human edits that follow, supporting a traceable review history.

    REVIEW HISTORY

Supplier context

The supplier signal
belongs in the investigation.

When a deviation involves supplier materials, external signals may add useful context to internal quality records. The proposed approach connects supplier-name and corporate-structure matching with curated FDA inspection observations and warning letters, and Health Canada inspection outcomes.

Supplier intelligence is a context layer inside the workflow. A regulatory signal informs human review; it does not establish the root cause of a particular deviation.

Boundaries by design

A copilot alongside
your quality system.

Evidence-linked drafting

Intended to help quality teams assemble and review documentation while preserving source references.

Controlled customer data

Customer document isolation by default. Cross-customer training would require explicit permission and contractual safeguards.

Quality-unit authority

No autonomous investigation conclusions, CAPA approvals, product release or regulatory compliance decisions.

See the proposed architecture

VERIDIA BY BLUETHERA

Let’s build
with evidence.

We’re exploring technology collaborations and design-partner conversations to help shape a practical quality operations tool.

Discuss Veridia